{"brief_title": "This Study is to Assess the Efficacy and Safety of ZD6474 in Subjects With Non-small Cell Lung Cancer.", "brief_summary": "The purpose of this study is to assess the efficacy and safety of ZD6474 in patients with NSCLC after Failure of Prior Platinum-based Chemotherapy.", "condition": ["Non-Small Cell Lung Cancer (NSCLC, Locally Advanced or Metastatic, Second-line"], "intervention_type": ["Drug", "Drug", "Drug"], "intervention_name": ["ZD6474", "Placebo", "Docetaxel"], "criteria": "Inclusion Criteria: - Histologic or cytologic confirmation of NSCLC (locally advanced or metastatic, IB-IV) - Failure of first-line platinum-based chemotherapy Exclusion Criteria: - Mixed small cell or non-small-cell histology - Bronchoalveolar carcinoma - Prior chemotherapy or herbal preparations must be discontinued more than 4 weeks before the start of study therapy (6 weeks for nitrosoureas, mitomycin and suramin) - Prior treatment with docetaxel", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "mesh_term": ["Lung Neoplasms", "Carcinoma, Non-Small-Cell Lung", "Docetaxel"], "id": "NCT00047840"}